UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain

The European journal of health economics, 2015-11, Vol.16 (8), p.895-905

2015

Volltextzugriff (PDF)

Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

Value in health, 2014-11, Vol.17 (7), p.A526-A526

2014

Volltextzugriff (PDF)

Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

Value in health, 2014-11, Vol.17 (7), p.A622-A622

2014

Volltextzugriff (PDF)

Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

Value in health, 2013-11, Vol.16 (7), p.A400-A400

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Value in health, 2013-11, Vol.16 (7), p.A623-A623

2013

Volltextzugriff (PDF)

Disability adjusted life years lost due to diabetes in france, Italy, Germany, Spain and the United Kingdom: A burden of illness study

Value in health, 2014-05, Vol.17 (3), p.A262-A262

2014

Volltextzugriff (PDF)

PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

Value in health, 2012-11, Vol.15 (7), p.A327-A327

2012

Volltextzugriff (PDF)

PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

Value in health, 2012-11, Vol.15 (7), p.A328-A328

2012

Volltextzugriff (PDF)

PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

Value in health, 2011, Vol.14 (7), p.A489-A489

2011

Volltextzugriff (PDF)

Patient preferences for osteoporosis in Spain: a discrete choice experiment

Osteoporosis international, 2011-06, Vol.22 (6), p.1947-1954

2011

Volltextzugriff (PDF)

A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

Value in health, 2013-11, Vol.16 (7), p.A379-A379

2013

Volltextzugriff (PDF)

PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

Value in health, 2011, Vol.14 (7), p.A411-A411

2011

Volltextzugriff (PDF)

PMS48 Cost-Utility of Denosumab for the Treatment of Postmenopausal Osteoporosis in Spain

Value in health, 2011, Vol.14 (7), p.A311-A311

2011

Volltextzugriff (PDF)

PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting

Value in health, 2011, Vol.14 (7), p.A490-A490

2011

Volltextzugriff (PDF)

PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

Value in health, 2011, Vol.14 (7), p.A371-A372

2011

Volltextzugriff (PDF)

PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

Value in health, 2012-11, Vol.15 (7), p.A542-A542

2012

Volltextzugriff (PDF)

PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

Value in health, 2011, Vol.14 (7), p.A452-A452

2011

Volltextzugriff (PDF)

PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated Cohort

Value in health, 2011, Vol.14 (7), p.A435-A436

2011

Volltextzugriff (PDF)

Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain

ClinicoEconomics and outcomes research, 2015-01, Vol.7 (default), p.387-395

2015

Volltextzugriff (PDF)

PSY28 - Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

Value in health, 2014-11, Vol.17 (7), p.A526-A526

2014

Volltextzugriff (PDF)

PCV114 - A Polypill Intervention To Improve Adherence For Secondary Cardiovascular Disease Prevention In Spain: A Cost-Effectiveness Study

Value in health, 2015-11, Vol.18 (7), p.A393-A394

2015

Volltextzugriff (PDF)

Hospital Cost Analysis Of Patients With Cardiovascular Events And Revascularisation Procedures In Spain

Value in health, 2015-11, Vol.18 (7), p.A385-A385

2015

Volltextzugriff (PDF)

A Polypill Intervention To Improve Adherence For Secondary Cardiovascular Disease Prevention In Spain: A Cost-Effectiveness Study

Value in health, 2015-11, Vol.18 (7), p.A393-A394

2015

Volltextzugriff (PDF)

PCV68 - Hospital Cost Analysis Of Patients With Cardiovascular Events And Revascularisation Procedures In Spain

Value in health, 2015-11, Vol.18 (7), p.A385-A385

2015

Volltextzugriff (PDF)

PSS7 THE ECONOMIC COST OF TREATING PATIENTS WITH AGE-RELATED MACULAR DEGENERATION IN SPAIN

Value in health, 2010, Vol.13 (7), p.A398-A398

2010

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain

Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Disability adjusted life years lost due to diabetes in france, Italy, Germany, Spain and the United Kingdom: A burden of illness study

PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

Patient preferences for osteoporosis in Spain: a discrete choice experiment

A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

PMS48 Cost-Utility of Denosumab for the Treatment of Postmenopausal Osteoporosis in Spain

PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting

PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated Cohort

Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain

PSY28 - Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

PCV114 - A Polypill Intervention To Improve Adherence For Secondary Cardiovascular Disease Prevention In Spain: A Cost-Effectiveness Study

Hospital Cost Analysis Of Patients With Cardiovascular Events And Revascularisation Procedures In Spain

A Polypill Intervention To Improve Adherence For Secondary Cardiovascular Disease Prevention In Spain: A Cost-Effectiveness Study

PCV68 - Hospital Cost Analysis Of Patients With Cardiovascular Events And Revascularisation Procedures In Spain

PSS7 THE ECONOMIC COST OF TREATING PATIENTS WITH AGE-RELATED MACULAR DEGENERATION IN SPAIN

Suchergebnisse filtern